| INTRODUC TI ON
Constant evolution of influenza viruses requires possible reformulation of the influenza vaccine every season. In February each year, the World Health Organization (WHO) organises a technical consultation to decide which influenza strains to be included in the Northern Hemisphere seasonal influenza vaccines. 1 Most groups for whom the seasonal influenza vaccine is recommended may receive a trivalent or quadrivalent inactivated seasonal influenza vaccine annually irrespective of their previous influenza virus infections or influenza vaccination history. In children less than 9 years old, one dose of inactivated influenza vaccine is recommended for children vaccinated in previous season and two doses for those previously unvaccinated. 2 Several observational studies and meta-analyses have reported inconsistent results of the effect of previous vaccination on current season influenza vaccine effectiveness (VE). [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Some suggest that previous vaccination may reduce the effectiveness of vaccination in the current season. 3, 5, 6 Various explanations were proposed. The original "antigenic sin" hypothesis suggests that vaccination primarily boosts pre-existing antibody responses that cross-react with the vaccine strain rather than producing a de novo response to the vaccine or infecting strain. 13 The "antibody block" hypothesis suggests that previously vaccinated individuals do not have the crossprotective immunity provided by natural infection. 14, 15 According to the "antigenic distance" hypothesis, in seasons when similar strains are included in the subsequent vaccines but are different from the circulating strain, previous vaccination may negatively interfere with current vaccination. 16 Finally, because the influenza vaccine is recommended to individuals with high-risk conditions (eg pregnant women, persons with chronic conditions, older adults aged >59 or >64 years), characteristics of individuals repeatedly vaccinated may result in a poorer observed response to the vaccine if we fail to control for negative confounding. 4 Due to the frequent changes of the genetic and antigenic characteristics of the circulating influenza strains and of those included in the vaccines, data from multiple seasons are needed to measure the potential effects of previous vaccinations and to explore the possible mechanism(s) that may explain such effects.
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In this article, using the I-MOVE primary care multicentre casecontrol study (MCCS) data, we present influenza type-/subtypespecific VE stratified by previous season vaccination among 
| ME THODS
Each season we conducted a primary care-based test-negative design MCCS. The methods were described previously and are based on the same generic study protocol. violated, 20 we carried out a sensitivity analysis using Firth's method of penalised logistic regression to check for small sample bias.
| RE SULTS

| Recruitment
From season 2011/2012 to 2016/2017, we included between 6 (in 2013/2014) and 12 (in 2015/2016, 2016/2017) sites in the pooled analysis of our multicentre study (Table 1) . GPs enrolled 10 831 ILI patients, aged 9 years or older, belonging to the groups targeted for influenza vaccination. Of these, we excluded 368 individuals with missing information on current season vaccination and 405 on previous vaccination. The proportion of individuals excluded due to missing information on current or previous season was 6.9% among cases and 7.3% among controls (Fisher's exact test, P = .365). The median age was 63 and 60 years for those with missing and complete information for vaccination status, respectively (P < .001).
Of the 10 058 ILI individuals with information on current and previous season vaccination status, 19 (0.2%) had influenza virus coinfections reported and were considered in more than one influenza type/subtype analyses. We therefore included 5532 (54.9%)
ILI patients negative for all influenza viruses and 941 (9.3%), 2645 (26.2%) and 959 (9.5%) positive for influenza virus A(H1N1)pdm09, A(H3N2) and B, respectively ( Table 2 ).
The median age was 54, 55, 63 and 61 years among influenza A(H1N1)pdm09, influenza B cases, influenza A(H3N2) cases and controls, respectively.
The proportion of vaccinated with current season vaccine was 32% among controls and 20%, 31% and 21% among influenza A(H1N1)pdm09, A(H3N2) and B cases, respectively ( Table 2 ). The proportion of quadrivalent vaccines used among those with known vaccine brand was <1%.
In each analysis, among cases and controls, less than 6% were vaccinated in the current season only and less than 8% in the previous season only. More than 60% of cases and controls were unvaccinated in both current and previous season and less than 27% were vaccinated in both seasons ( Table 2 ).
The proportion of controls 65 years and older among those vaccinated in both seasons was 64.3% compared to 44.2%, 42.0% and 27.1% among those vaccinated in the previous season only, vaccinated in the current season only and not vaccinated in either season (Table 3) .
| Vaccine effectiveness
We included four influenza seasons for the influenza A(H1N1)pdm09
and A(H3N2) analysis and two for the influenza B analysis (Table 4) . 
| Current season VE
Influenza A(H3N2)
We could compute VE stratified by previous vaccination status in three of the four seasons. In these three seasons, current season VE point estimate among those vaccinated in previous season was negative (−68%, −21% and −19% in 2011/2012, 2014/2015, 2016/2017, respectively) and lower than among those unvaccinated in previous season (33%, 48% and 46% in 2011/2012, 2014/2015 and 2016/2017, respectively) ( Table 1) . (Table 1) .
Influenza
| Indicator analysis, using those unvaccinated in both seasons as reference
Influenza A(H1N1)pdm09
In 2013/2014, the VE point estimate for vaccination in both current and previous seasons was higher than that for vaccination in the current season only (Table 5 ). In the other three seasons, VE point estimates for vaccination in both seasons were lower than those (Table 5) .
Influenza A(H3N2)
In 2013/2014, 2014/2015 and 2016/2017 , VE point estimates for vaccination in both current and previous seasons were lower than those for vaccination in current season only (Table 5 ). In I-MOVE 2011 I-MOVE /2012 I-MOVE -2016 I-MOVE /2017 
TA B L E 2 (Continued)
2011/2012, VE point estimates for those two groups were similar (less than 9% absolute difference). VE point estimates, for vaccination in previous season only, ranged from 15% to 60% (Table 5) .
Influenza B
In 2012/2013, the VE point estimate for vaccination in both current and previous seasons was higher than that for vaccination in current (Table 5 ).
| Sensitivity analysis
Where the EPV was <10, penalised and standard logistic regression VE estimates did not differ by more than 6.5% absolute, with an average of 3.4%, for both the stratified and indicator analyses, indicating little bias due to sparse data. Our study has several limitations. Even though our analysis is restricted to the target group for vaccination, the vaccination coverage is still low (6%, 7% and 26% of controls vaccinated in current season only, in previous season only and in both seasons, respectively). This results in a low precision and high variability of the results.
| D ISCUSS I ON
TA B L E 4 Predominant influenza strains circulating and influenza strains included in the vaccines in
Past infections and natural immunity play an important role in the protection against circulating influenza strains 22,23 and may strengthen the response to subsequent vaccines. 24 Measuring immunity conferred by past infection is challenging. An immunological study suggests that the response to inactivated influenza vaccines is lower among individuals previously vaccinated than among individuals with previous natural influenza A(H1N1)pdm09 virus infection. 25 In a hospital-based study in Japan, a negative effect of previous vaccination on current season vaccine effectiveness was observed in individuals not infected but not in individuals infected with influenza A virus in the previous season. 8 Individuals in the same age group may have had similar exposure to previous circulating influenza viruses, resulting in a similar influenza antibody landscape. [26] [27] [28] In our study, the low vaccination coverage and number of cases in some age groups did not allow for estimation of results by age group.
We only collected information on the effect of one previous season vaccination and were not able to take into account the role of repeated previous vaccinations. In a study using eight seasons' pooled data and five previous years of historical vaccination, VE was similar for those vaccinated in the current season and those vaccinated in current and previous seasons. 4 However, VE was lower for current season in the group of individuals vaccinated at least in two of five seasons than in individuals never vaccinated in the five seasons.
We documented the vaccine type for the current season but not for the previous season. Studies suggest that the type of vaccine received in current or previous season may influence the effect of previous vaccination in current season VE. 4, 7 In our study, four types of vaccines were used: egg-derived inactivated subunit, eggderived inactivated split virion, cell-derived inactivated subunit and adjuvanted vaccines (adjuvant used: squalene (MF59) or aluminium phosphate gel). We could not stratify VE results by type of current and previous vaccines.
While the test-negative design attempts to control for bias due to differential healthcare-seeking behaviours, 29 the study is observational and subject to the usual limitations, in particular adequately controlling for confounding.
| Results interpretation
| Influenza A(H1N1)pdm09
The 
| Influenza A(H3N2)
We observed that in all seasons, A(H3N2) VE point estimates were lower among those vaccinated in the previous season than in those unvaccinated in previous season.
Using unvaccinated in both seasons as reference, VE of var- 
| Influenza B
The low precision of the VE against influenza B did not allow us to identify any pattern of the effect of previous vaccination. However VE point estimates for vaccination in current season only were always positive and VE point estimates for vaccination in previous season only were low or negative. We could not measure VE by influenza B lineage which limits interpretation.
| CON CLUS ION
We cannot exclude that being vaccinated in the previous season may reduce the VE of the current season vaccine, in particular for A(H3N2). However, the positive VE results among those vaccinated in current season only and those vaccinated in both seasons in this study suggest that being vaccinated in a given season is always beneficial. 
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